The metacarpal bone mineral density (BMD) and metacarpal index (MCI) of the second metacarpal bone were measured by computed X-ray densitometry (CXD) (Teijin Ltd., Tokyo), which we have established with the development of microdensitometry of radiographs. In this study, we evaluated the basic attributes of this CXD method and determined the age-related changes in both metacarpal measurements in normal Japanese women. The precision in vivo was measured in eight subjects. The precision errors [coefficient of variation (CV)] were 0.2-1.2% CV for metacarpal BMD and 0.4-2.0% CV for MCI, respectively. We have obtained low precision error and more rapid analysis, within 3 minutes respectively, compared with the previous methods. Age-related changes in the metacarpal measurements were evaluated in 1438 normal women. Both measurements showed the most significant decrease in the sixth decade of life. The rate of decrease in the sixth decade was 1.6%/year for metacarpal BMD and 1.5%/year for MCI. On comparison between metacarpal BMD by CXD and spine BMD using dual energy X-ray absorptiometry (DXA) in 248 normal women with and without menstruation, the two measurements were found to be similarly decreased in the subjects within 5 years after menopause. There was also no significant difference in the Z-score between metacarpal BMD and spine BMD within 5 years after menopause. These results indicate that early postmenopausal bone loss occurs not only in the spine but also in the metacarpal bone. The metacarpal BMD for patients with osteoporosis was significantly lower than that for age-matched normal controls, although the Z-score for spine BMD (-1.46) was significantly better than that for metacarpal BMD (-0.82). In conclusion, because CXD has excellent low precision error and is widely available at relatively low cost, it appears potentially to be applicable to problems in the diagnosis and management of osteoporosis, when used in association with DXA.
with calipers or a digitizer [2--4] . On the other hand, in order to obtain measurement on bone density with low precision error, several techniques for hand radiograph photodensitometry were further developed involving the use of a densitometer with a computer [5] [6] [7] or a television camera with a computer [8, 9] . The rationale for the method is based on several basal studies [10] [11] [12] . Colbert, [10] Trouerbach, [6] and others have used computerized analysis of radiographs to provide readings of optical density. One of these photodensitometry techniques has already been reported, i.e., microdensitometry of radiography (MDR), which was developed by the authors in 1980 [13] [14] [15] . The principles of the MDR and the computed X-ray densitometer (CXD) method, which will be described in this paper, are very similar. Both techniques calibrate optical densities of X-ray films using an aluminum step wedge to measure metacarpal bone mineral density (BMD) and the metacarpal index (MCI). In Japan, MDR has been applied for clinical use in the diagnosis and management of osteoporosis and related diseases [16] . It is acknowledged that photodensitometry of hand radiographs is a practical and relatively inexpensive way of determining the BMD, and can be performed at any facility that has ordinary X-ray equipment. The MDR method, however, requires much manual work during which observer error may arise; its precision errors (CV) are 3-5% [14] . Thus, for lower precision error and more rapid analysis, we have developed the CXD method through the improvement of MDR [17] . The differences of MDR and CXD will be discussed in detail in the materials and methods section.
In this study, the basic attributes of CXD were evaluated, and age-related changes in both metacarpal measurements were investigated in normal Japanese women using CXD. Regarding the metacarpal bone, if it closely reflects bone changes in the axial bone where osteoporotic fractures occur, it has not been thoroughly investigated. Therefore, we evaluated the reliability and validity of the metacarpal measurements using CXD in detecting postmenopausal bone loss and screening for osteoporosis.
The measurement of bone mass using hand radiographs (radiogrammetry) was first developed by Barnett and Nordin [1] . With the radiogrammetry technique, the metacarpal cortical thickness and metacarpal cortical area are measured
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Materials and Methods

Computed X-ray Densitometer
Both the MDR and the CXD methods measure bone density and cortical thickness at the middle of the second metacarpal bone, using posterior-anterior X-ray radiographs of the hand and an aluminum step wedge (20 steps, 1 ram/step) as a standard. Table 1 shows the differences in two methods on the process for measurement. With the MDR method (Fig. 1) , a reference line should be manually 
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2) MCl =----5-- Fig. 1 . Densitometric pattern on microdensitometry of a hand radiograph or computed X-ray densitometry, and metacarpal measurements. The optical density was measured at the midpoint of the second metacarpal bone on an X-ray radiograph. From the densitometric pattern, the two parameters were measured and converted to the step numbers on the aluminum step wedge. The intensity of light from the LED can be adjusted according to the condition (the degree of whitening) of a radiograph. Using the cursor, the examiners indicate the location of the head and two points at the base of the second metacarpal bone to determine its middle basepoint. With these head and middle basepoint, a longitudinal axis can be determined and bone rnmass will be measured on the middle of the longitudinal line. Then these data are displayed on the screen as a densitometric pattern. The parameters, metacarpal BMD and MCI, are both calculated using the density data for the aluminum step wedge. All of these analyzing processes, except identification of the line for measurement, are controlled by a computer and are executed automatically unlike in the case of the MDR. The measuring time with this method requires only 3 minutes. Also, the CXD method has several improvements in the software compared with MDR. In X-ray images, random noise from the grain marks in the film causes some errors in the parameters related to bone density~ This random noise can be reduced by merging densitometric curves along an appropriate number of scanning lines. In CXD, the noise is reduced to less than 0.05 mm by merging the densitometric curves of 21 lines. MCI is obtained at a pitch of 0.0635 mm from an area of 1.3 mm, as in the case of the MDR method. However, metacarpal BMD was obtained at a pitch of 0.3175 mm from an area of 6_35 mm (increased 5 times compared with the MDR method). These modifications are made to reduce radiographic errors and to improve the reproducibility of each parameter.
Reproducibility
The precision in vitro was examined for 7 days by taking radiography of three aluminum phantoms (Teijin Ltd., Tokyo) in air with a standard aluminum step wedge. The precision in vivo was determined in 11 subjects, including young adults (6 men and 2 women), mean age 46.3 _+ 11.1, and 3 osteoporotic women, mean age 83 + 5, mean height 140.9 ___ 6.7 cm, and mean weight 43.1 -+ 8.5 kg. Radiographs were taken of the hands of four subjects three times with repositioning on the same day for scans using CXD. With these results, the short term precision was determined. To determine the midterm precision, radiographs were taken of the hands of four subjects on 3 different days with scanning by CXD, The reproducibility of CXD on osteoporotic patients was determined for three subjects by scanning three radiographs taken on the same day. determined, which crosses the middle point of the longitudinal axis of the second metacarpal bone. The selected reference line is scanned with a microdensitometer and the measured quantity of light permitted through the line is recorded on a chart. Then, the radiography of an aluminum step wedge, as a standard, is performed along its longitudinal axis with the microdensitometer, and the measured quantity of light that is permitted through the aluminum step wedge is recorded on a diagram on the chart. Then, the diagram of the quantity of absorbed light is converted to digital data by a digitizer, and the digital data are then sent to an electronic computer for conversion of the quantities of absorbed light at the line on the metacarpal bone into the corresponding gradations on the aluminum step wedge, as a standard. The computer then calculates the metacarpal BMD and MCI on the basis of the pattern expressed as the gradations on the aluminum step wedge. The measured BMD can be expressed as the thickness of an aluminum equivalent (ram A1) showing corresponding X-ray absorption. MCI ((dl + d2)/D) expresses the degree of cortical thickness, and dl and d2 are each determined from the two peaks of the densitometric curve which correspond to medullary space of the metacarpal bone.
On the other hand, the apparatus with the CXD is a desktop-
Bone Mass Measurement in Normal and Osteoporotic Women
Normal Japanese volunteers, all residents of Hamamatsu and Shizuoka cities, Shizuoka Prefecture, served as subjects for studying age-related changes in the metacarpal bone in normal Japanese females. All were volunteers and gave informed consent prior to the study. Each subject was given a detailed medical questionnaire to determine her eligibility for participation in this study. Radiography of the hands was taken in all of the subjects, and both metacarpal BMD and MCI were calculated by CXD. The subjects who were under medical treatment for conditions known to affect bone metabolism, such as hyperthyroidism, renal disease, collagen disease, or ovarian tumors, were excluded from the study. Also the subjects who had a history of symptomatic fractures of the hip or vertebra were excluded. Finally, standard values with the CXD method in each decade of life were calculated for 1438 females who ranged in age from 20 to 89 years, using Hoffmann's method, all values out of the mean +-2 SD ranges being excluded.
In 248 of the subjects ranging in age from 24 to 70, BMD of the lumbar spine was also measured with DXA using a Lunar DPX-L (Lunar Corp., Madison WI, USA). These subjects were investigated for the purpose of examining the postmenopausal metacarpal bone loss in compared with the postmenopausal spinal bone loss. The results were analyzed in relation to the menstrual status and the number of years past menopause. The subjects were classified into two groups for cross-sectional study: group 1, premenopausal subjects with a regular menstrual cycle (n = 143); group 2, postmenopausal subjects (more than 1 year since last menstruation) subjects (n = 105). Group 2 was further subdivided into four subgroups according to the number of years since the menopause (1-5, 6-10, 11-15, and [16] [17] [18] [19] [20] .
Comparisons were made of the differences between CXD measurements of the second metacarpal bone and BMD of the lumbar spine for 40 osteoporosis patients over the age of 50 years (average age 64 +-3 years), who exhibited at least one atraumatic vertebral compression deformity in radiographs of the lumbar or thoracic spine. Definite flattening (>20%) or anterior wedge deformity of a vertebral body was accepted as vertebral compression. Comparisons were made in 36 age-matched normal women. Group differences were expressed as Z-scores, as well as percentages; the SD for the normal women was used to calculate the Z-score.
Statistical Analysis
Comparisons of the values of both CXD and DXA among different age groups or different menstruation status groups, and the Z-scores between normal control subjects and the subjects with osteoporosis were performed using one-way analysis of variation (ANOVA), followed by the Turkey-Kramer method. Student's t-test was used to compare spine BMD and metacarpal BMD between normal control and osteoporotic subjects. Differences in means were considered statistically significant if the P values were <0.05. 
Results
Reproducibility
The reproducibility for CXD is shown in Table 2 . The CVs in vitro were 1.2-1.7% for metacarpal BMD and 1.1-1.8% for MCI. The midterm precision errors in vivo were 0.2-0.8% CV for metacarpal BMD and 0.6-1.5% CV for MCI, and the short-term precision errors in vivo were 0.3-1.2% CV for metacarpal BMD and 0.4-2.0% CV for MCI. In osteoporotic patients, the reproducibilities were 1.5-2.3% CV for metacarpal BMD and 1.4-2.7% CV for MCI.
Age-Related Changes in Metacarpal Measurements Using CXD Among Normal Japanese Women
The metacarpal measurements in normal women are shown in Table 3 . Metacarpal BMD peaked in the 30-39-year age group, then decreased gradually until age 50, but decreased markedly after age 50. MCI peaked in the 40--49-year age group and then decreased. The first significant losses in metacarpal BMD and MCI were observed after age 50 (P < 0.001). There were decreases of 30.7% in metacarpal BMD and 29.5% in MCI over the period from age 40--49 years to age 70-79 years. Significant decrease in metacarpal BMD was observed 1.6%/year from age 50 to 59, and 1.4%/year from age 60 to 69. Significant decrease in MCI was 1.5%/ year from age 50 to 59, and 1.0%/year from age 60 to 69. As these findings seem to indicate that the menopause affected the change in the metacarpal measurements, the relationship between the menstrual status and the number of years since the menopause for metacarpal BMD was investigated. Simultaneously, postmenopausal metacarpal bone loss was compared with the spinal bone loss (Table 4) . Statistically significant differences in both spine BMD and metacarpal BMD were observed between the premenopausal group and the 1-5 years after menopause group. Also, obvious decreases in spine BMD were observed following the menopause, which continued 1-5 years later. Metacarpal BMD decreased 6.8% during those 5 years, and spine BMD decreased 11.3%. For the 1-5 and 6-10 years after menopause groups, and the 6-10 and 11-15 years after menopause groups, there was no significant decrease in either metacarpal BMD or spine BMD. For the 1-5, 6-10, and 11-15 years after menopause groups, there was no significant difference in the Z-score between spine BMD and metacarpal BMD. For the 16-20 years after menopause group, a significant difference was observed in the Z-score between spine BMD and metacarpal BMD.
Comparison Between Osteoporotic Patients and Age-Matched Controls
Metacarpal BMD in the patients with osteoporosis was significantly lower than that in the age-matched controls ( Table  5 ). The osteoporotic subjects weighed 43.8 kg on average, and were 148.2 cm tall on average; controls were slightly heavier and taller, but the differences were not significant (51.1 kg and 151.5 cm on average). The Z-score for spine BMD (-1.46) was significantly superior to that for metacarpal BMD (-0.82). P < 0.001 vs. the value in the 40-49 year age group b p < 0.001 vs. the value in the 50-59 year age group c p < 0.001 vs. the value in the 60--69 year age group a, b, c: Comparisons of the values among different age groups were performed using ANOVA a There was a 1-2 cm difference in height and a 2-3 kg difference in weight between the average values for our subjects and the corresponding values for the national average, as calculated by the Japanese Ministry of Health and Welfare in 1991 [35] e Annualized % change in metacarpal BMD was calculated by linear regression in each age group f Annualized % change in MCI was calculated by linear regression in each age group 
Discussion
Among the technologies available for the measurement of bone mass are single photon absorptiometry (SPA), dual photon absorptiometry (DPA), quantitative computed tomography (QCT), and DXA. All of these methods, however, have advantages and disadvantages, and at present there is no consensus as to which is the optimal one. A more rapid, less costly, and more widely accessible, yet similarly accurate method of determining bone mass would therefore be useful in many clinical and research settings as the incidence of osteoporosis has been increasing, particularly in Japan.
Photodensitometry and radiogrammetry are probably the simplest techniques for obtaining quantitative information concerning the bone mineral content. The CXD method, which we developed through improvement of MDR, offers much lower precision error than either the other photodensitometries [5] [6] [7] [8] [9] or radiogrammetry [18, 19] , and further constitutes a remarkably rapid way of measuring bone mass--only 3 minutes being required for analysis. The precision of CXD in our study, as we have already reported [17, 20] , is almost the same as that of DXA, which is known as the most reliable means of bone mass measurement [21, 22] . We have achieved remarkably low precision error and more rapid analysis through the automatization of most of the processes that were formerly performed manually, and through improvements of the software used with computers. On bone mass measurement using radiography, account must be taken for error due to soft tissue, unless a waterbath is used. However, without any use of a waterbath, we obtained satisfactorily low precision error both in vitro (phantom in air) and in vivo.
Although some researchers have reported in detail on their research on the metacarpal measurements [3] [4] [5] , there has been no reports of the use of CXD; therefore, for clinical application of the CXD method, we first studied the measurement of both metacarpal BMD and MCI in normal Japanese women using CXD. Metacarpal BMD peaked at the ages of 30-39 years, followed by a significant decrease after age 50. The changes in MCI were found to be similar. The rate of decrease in both metacarpal BMD and MCI was highest in the 50-59-year age group (1.6%/year for metacarpal BMD and 1.5%/year for MCI). These results suggest that metacarpal bone loss occurs in the early postmenopausal period. Some studies have shown that the cortical bone mass decreases during the mid-thirties, then decreases slowly (0.2-0.3%/year) until age 50, and finally accelerates sharply (0.8--0.9%/year) until age 75 [23] . On the other hand, in some studies, DXA or DPA was recently used to measure changes in cancellous bone with age [24] [25] [26] [27] . Kin etal. [27] reported that for spine BMD, using DXA, the rate of decrease is 16.9% between both the ages of 40 and 49 and 50 and 59. In addition, it is generally acknowledged that the early postmenopausal bone loss involves cancellous bone rather than cortical bone [28] and the distribution of bone mass differentiates cancellous bone from cortical bone. However, there is, little information on the relationship between metacarpal measurements and bone density measurement of the spine [29] . On comparison between metacarpal BMD and spine BMD following our data, the two measurements were found to similarly decrease within 5 years after menopause. There is also no significant difference in the Z-score between metacarpal BMD and spine BMD within 5 years after menopause, although the sensitivity of the latter appeared to be slightly higher. These results indicated that the early postmenopausal bone loss arises not only in the spine but also in the metacarpal bone. Therefore, using a more precise and reliable measurement tool such as CXD, cortical bone mass measurement could detect the early postmenopausal bone loss in a large number of postmenopausal women.
Low bone density is now recognized as the most important determinant of fracture risk, and accounts for the majority of fractures in the elderly. With regard to the ability to predict osteoporotic fracture risk by appendicular bone mass measurement, recent studies indicated that in the majority of postmenopausal women with previous vertebral fracture, the metacarpal cortical thickness is more than two SDs below the normal young female mean [30] , and that metacarpal morphometry may allow prediction of the risk of hip fracture [311.
Riis and Christiansen [32] compared the results obtained with SPA in forearm bones with those with DPA in the lumbar spine, and concluded that the former were superior, both in clinical studies and in individual patient, for detecting estrogen-dependent bone loss and its treatment by estrogen replacement. Recently Black et al. [33] also showed that BMD of the radius did predict hip fractures in women, though it was less predictive than BMD of the femur [33] . On the other hand, others have found less satisfactory correlation between appendicular and axial measurements [34] ; the reason for this controversy remains unclear. In our study concerning vertebral fracture risk, the sensitivity of metacarpal BMD was not found to be superior enough over that of spine BMD with DXA. Also there is indeed, a significant difference between age-matched normal women and osteoporotic patients in metacarpal BMD. Although DXA measurements of the spine are reliable predictors of vertebral fracture risk, DXA is probably inappropriate for mass screening for osteoporosis, because measurement is more expensive and it requires more space for the machinery. As very large populations are involved, such screening should be as inexpensive as possible and could easily be performed in smaller centers with limited resources. The availability of existing equipment with adequate methodologic-sensitivity is a decisive advantage in screening for osteoporotic fracture risk in postmenopausal women.
In conclusion, because CXD has excellent low precision error and is widely available at relatively low cost, it appears to be potentially applicable to problems in the diagnosis and management of osteoporosis, when used in association with DXA.
